Evidence map›Paper›PMID 34566948›Full record

ArticleFrontiers in immunology2021

The CSF1R-Microglia Axis Has Protective Host-Specific Roles During Neurotropic Picornavirus Infection.

John Michael S Sanchez, Ana Beatriz DePaula-Silva, Daniel J Doty, Tyler J Hanak, Amanda Truong, Jane E Libbey, Robert S Fujinami

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

John Michael S SanchezDepartment of Pathology, University of Utah School of Medicine, Salt Lake City, UT, United States.
Ana Beatriz DePaula-SilvaDepartment of Pathology, University of Utah School of Medicine, Salt Lake City, UT, United States.
Daniel J DotyDepartment of Pathology, University of Utah School of Medicine, Salt Lake City, UT, United States.
Tyler J HanakDepartment of Pathology, University of Utah School of Medicine, Salt Lake City, UT, United States.
Amanda TruongDepartment of Oncological Sciences, Huntsman Cancer Institute, Salt Lake City, UT, United States.
Jane E LibbeyDepartment of Pathology, University of Utah School of Medicine, Salt Lake City, UT, United States.
Robert S FujinamiDepartment of Pathology, University of Utah School of Medicine, Salt Lake City, UT, United States.
University of Utah · USHuntsman Cancer Institute · US

Funding

Training Program in Microbial PathogenesisT32AI055434 · NIAID · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI MULVEY, MATTHEW A, PLANELLES, VICENTE · 2004 to 2025
$6.0M
Virus-Host Interactions that Lead to EpilepsyR01NS065714 · NINDS · UNIVERSITY OF UTAH · PI FUJINAMI, ROBERT S · 2010 to 2018
$2.9M
Viral-induced axonopathy: mechanisms of damage and repairR01NS091939 · NINDS · UNIVERSITY OF UTAH · PI FUJINAMI, ROBERT S, LANE, THOMAS E · 2016 to 2020
$1.7M
NINDS NIH HHS R01 NS065714NINDS NIH HHS R01 NS091939
6 · The paper itself

Abstract

Viral encephalitis is a major cause of morbidity and mortality, but the manifestation of disease varies greatly between individuals even in response to the same virus. Microglia are professional antigen presenting cells that reside in the central nervous system (CNS) parenchyma that are poised to respond to viral insults. However, the role of microglia in initiating and coordinating the antiviral response is not completely understood. Utilizing Theiler's murine encephalomyelitis virus (TMEV), a neurotropic picornavirus, and PLX5622, a small molecule inhibitor of colony-stimulating factor 1 receptor (CSF1R) signaling that can deplete microglia in the CNS; we investigated the role of the CSF1R-microglia axis in neurotropic picornavirus infection of C57BL/6J and SJL/J mice. These mouse strains differ in their ability to clear TMEV and exhibit different neurological disease in response to TMEV infection. CSF1R antagonism in C57BL/6J mice, which normally clear TMEV in the CNS, led to acute fatal encephalitis. In contrast, CSF1R antagonism in SJL/J mice, which normally develop a chronic CNS TMEV infection, did not result in acute encephalitis, but exacerbated TMEV-induced demyelination. Immunologically, inhibition of CSF1R in C57BL/6J mice reduced major histocompatibility complex II expression in microglia, decreased the proportion of regulatory T cells in the CNS, and upregulated proinflammatory pathways in CNS T cells. Acute CSF1R inhibition in SJL/J mice had no effect on microglial MHC-II expression and upregulated anti-inflammatory pathways in CNS T cells, however chronic CSF1R inhibition resulted in broad immunosuppression. Our results demonstrate strain-specific effects of the CSF1R-microglia axis in the context of neurotropic viral infection as well as inherent differences in microglial antigen presentation and subsequent T cell crosstalk that contribute to susceptibility to neurotropic picornavirus infection.

Indexed as

AnimalsCardiovirus InfectionsFemaleMaleMiceMice, Inbred C57BLMicrogliaOrganic ChemicalsReceptors, Granulocyte-Macrophage Colony-Stimulating FactorTheilovirusCsf1r protein, mouseOrganic ChemicalsPLX5622Receptors, Granulocyte-Macrophage Colony-Stimulating Factordemyelinationinnate immunitymicrogliamultiple sclerosispicornavirusT cellTheiler’s murine encephalomyelitis virusvirology

Identifiers

PMID34566948
PMCPMC8458822
OpenAlexW3198737471

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.